Total Payments
$6,318
2024 Payments
$1,191
Companies
33
Transactions
305
Medicare Patients
12,856
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$6,318 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,318 | 305 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,384 | 73 | $0 (2024) |
| Amgen Inc. | $850.08 | 33 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $700.74 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $480.63 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $466.63 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $266.22 | 18 | $0 (2024) |
| Lilly USA, LLC | $216.57 | 11 | $0 (2023) |
| Incyte Corporation | $164.64 | 3 | $0 (2024) |
| Celgene Corporation | $162.46 | 3 | $0 (2017) |
| PFIZER INC. | $161.61 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,191 | 53 | Amgen Inc. ($199.18) |
| 2023 | $1,392 | 65 | Amgen Inc. ($245.46) |
| 2022 | $1,179 | 60 | Regeneron Healthcare Solutions, Inc. ($249.56) |
| 2021 | $1,221 | 62 | AbbVie Inc. ($369.22) |
| 2020 | $383.44 | 22 | AbbVie Inc. ($89.44) |
| 2019 | $169.74 | 10 | AbbVie, Inc. ($66.57) |
| 2018 | $228.47 | 13 | AbbVie, Inc. ($98.22) |
| 2017 | $553.64 | 20 | AbbVie, Inc. ($232.80) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.63 | General |
| Category: Immunology | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.92 | General |
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $66.28 | General |
| Category: Wound Care | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.15 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,704 | 6,871 | $2.2M | $495,336 |
| 2022 | 34 | 3,328 | 6,449 | $2.1M | $483,770 |
| 2021 | 34 | 3,039 | 5,861 | $1.9M | $474,384 |
| 2020 | 35 | 2,785 | 5,528 | $2.0M | $464,191 |
Total Patients
12,856
Total Services
24,709
Medicare Billing
$1.9M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 248 | 328 | $637,960 | $150,480 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 684 | 952 | $247,520 | $54,735 | 22.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 81 | 130 | $154,050 | $41,588 | 27.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 355 | 432 | $129,600 | $26,053 | 20.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 41 | 54 | $98,550 | $25,478 | 25.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 459 | 640 | $124,800 | $22,163 | 17.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 108 | 127 | $111,760 | $21,322 | 19.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 237 | 280 | $92,400 | $21,068 | 22.8% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 29 | 31 | $68,355 | $17,757 | 26.0% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 22 | 22 | $63,030 | $16,970 | 26.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 93 | 103 | $94,760 | $13,324 | 14.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 378 | 2,666 | $53,320 | $12,956 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 286 | 344 | $55,040 | $12,242 | 22.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 63 | 88 | $43,120 | $10,401 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 141 | 141 | $45,120 | $8,919 | 19.8% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 52 | 54 | $44,820 | $6,999 | 15.6% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 31 | 35 | $31,675 | $4,878 | 15.4% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 12 | 14 | $15,890 | $4,311 | 27.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 68 | 86 | $12,900 | $3,135 | 24.3% |
| 69100 | Biopsy of ear | Office | 2023 | 39 | 41 | $11,480 | $2,314 | 20.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $17,040 | $2,297 | 13.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $9,360 | $2,044 | 21.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 25 | $9,250 | $1,995 | 21.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 53 | 53 | $11,130 | $1,981 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 23 | $8,510 | $1,819 | 21.4% |
About Dr. Russell Akin, M.D
Dr. Russell Akin, M.D is a Procedural Dermatology healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346432440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Akin, M.D has received a total of $6,318 in payments from pharmaceutical and medical device companies, with $1,191 received in 2024. These payments were reported across 305 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,318).
As a Medicare-enrolled provider, Akin has provided services to 12,856 Medicare beneficiaries, totaling 24,709 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties MOHS-Micrographic Surgery, Dermatology
- Location Midland, TX
- Active Since 08/13/2007
- Last Updated 10/31/2019
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1346432440
Products in Payments
- DUPIXENT (Biological) $702.76
- Otezla (Drug) $666.56
- SKYRIZI (Biological) $583.85
- HUMIRA (Biological) $331.54
- Enbrel (Biological) $299.42
- TREMFYA (Drug) $296.66
- Humira (Biological) $266.83
- Sotyktu (Drug) $266.22
- TALTZ (Drug) $216.57
- COSENTYX (Drug) $184.80
- COSENTYX (Biological) $182.80
- OPZELURA (Drug) $164.64
- EUCRISA (Drug) $161.61
- Kerecis Omega3 SurgiClose (Device) $159.57
- STELARA (Biological) $151.53
- ADBRY (Biological) $103.24
- ILUMYA (Biological) $87.21
- LIBTAYO (Biological) $75.31
- DORYX (Drug) $63.29
- AXXENT SURFACE CONTROLLER (Device) $58.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.